IFNA1 and Autoimmunity: This mechanism has been proposed to contribute to the reduced Treg differentiation in SLE patients with an active type I IFN signature (42, 43), as well as to the increased incidence of secondary autoimmunity (44) and sustained reduction of Treg numbers (45) in patients treated with IFN-α.